Literature DB >> 16311085

Expression and regulation of CCN genes in murine osteoblasts.

Muriel S Parisi1, Elizabetta Gazzerro, Sheila Rydziel, Ernesto Canalis.   

Abstract

Members of the CCN family of genes include cysteine-rich 61 (CYR61), connective tissue growth factor (CTGF), nephroblastoma overexpressed (NOV), and Wnt-induced secreted proteins (WISP) 1, 2 and 3. CCN proteins play a role in cell differentiation and function, but their expression and function in skeletal tissue is partially understood. We examined the expression and regulation of CCN genes in primary cultures of murine osteoblasts treated with transforming growth factor beta (TGFbeta), bone morphogenetic protein (BMP)-2, or cortisol. Northern blot analysis revealed the presence of CYR61, CTGF, NOV, and WISP 1 and 2 transcripts in murine osteoblasts, but not WISP 3 transcripts. Northern and Western blot analyses revealed that TGF beta, BMP-2, and cortisol increased CYR61 and CTGF mRNA and protein levels. TGF beta decreased NOV and increased WISP 2 mRNA and protein levels, and TGF beta and BMP-2 increased, whereas cortisol decreased WISP 1 mRNA and protein levels. Nuclear run-on assays revealed that TGF beta, BMP-2 and cortisol enhanced CYR61 and CTGF transcription, TGF beta and BMP-2 induced and cortisol suppressed WISP 1, and TGF beta induced WISP 2 transcription. Suppression of NOV transcription could not be detected due to low control levels. In conclusion, five of the six known CCN genes are expressed by osteoblasts and their transcription is regulated by TGF beta, BMP-2 and cortisol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311085     DOI: 10.1016/j.bone.2005.10.005

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  44 in total

1.  Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.

Authors:  Ernesto Canalis; Stefano Zanotti; Wesley G Beamer; Aris N Economides; Anna Smerdel-Ramoya
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

Review 2.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  CCN5: biology and pathophysiology.

Authors:  Joshua W Russo; John J Castellot
Journal:  J Cell Commun Signal       Date:  2010-09-21       Impact factor: 5.782

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 5.  Genomic profiling of mesenchymal stem cells.

Authors:  Danijela Menicanin; P Mark Bartold; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cell Rev Rep       Date:  2009-02-18       Impact factor: 5.739

6.  CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.

Authors:  Jen-Liang Su; Jean Chiou; Chih-Hsin Tang; Ming Zhao; Chun-Hao Tsai; Pai-Sheng Chen; Yi-Wen Chang; Ming-Hsien Chien; Chu-Ying Peng; Michael Hsiao; Ming-Liang Kuo; Men-Luh Yen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

7.  Connective tissue growth factor in regulation of RhoA mediated cytoskeletal tension associated osteogenesis of mouse adipose-derived stromal cells.

Authors:  Yue Xu; Diane R Wagner; Elena Bekerman; Michael Chiou; Aaron W James; Dennis Carter; Michael T Longaker
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

8.  Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis.

Authors:  Ernesto Canalis; Anna Smerdel-Ramoya; Deena Durant; Aris N Economides; Wesley G Beamer; Stefano Zanotti
Journal:  Endocrinology       Date:  2009-11-24       Impact factor: 4.736

9.  CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Darryl R Peterson; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

10.  CCN3 and bone marrow cells.

Authors:  Ken-Ichi Katsube; Saki Ichikawa; Yuko Katsuki; Tasuku Kihara; Masanori Terai; Lester F Lau; Yoshihiro Tamamura; Shin'ichi Takeda; Akihiro Umezawa; Kei Sakamoto; Akira Yamaguchi
Journal:  J Cell Commun Signal       Date:  2009-07-23       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.